Preclinical News and Research

RSS
U.S.-Chile collaborate to study new long-acting local anesthetic derived from algae

U.S.-Chile collaborate to study new long-acting local anesthetic derived from algae

Unigene accelerates UGP281 anorexigenic peptide to treat obese patients

Unigene accelerates UGP281 anorexigenic peptide to treat obese patients

Opsens completes pre-clinical EasyWire device study for measurement of FFR in coronary arteries

Opsens completes pre-clinical EasyWire device study for measurement of FFR in coronary arteries

EpiCept 2010 fourth quarter net loss is $0.06 per share

EpiCept 2010 fourth quarter net loss is $0.06 per share

PCI Biotech completes patient inclusion in PC-A11 phase I/II study to treat cancer

PCI Biotech completes patient inclusion in PC-A11 phase I/II study to treat cancer

Trevena commences TRV120027 Phase 2a trial in patients with acute heart failure

Trevena commences TRV120027 Phase 2a trial in patients with acute heart failure

Aestus commences ATx08-001 phase 2 trial to evaluate efficacy of novel pain therapeutic

Aestus commences ATx08-001 phase 2 trial to evaluate efficacy of novel pain therapeutic

Aeterna to present two novel anticancer compounds at Bio Partnering North America conference

Aeterna to present two novel anticancer compounds at Bio Partnering North America conference

ISCTM 7th annual meeting to discuss drug development based on amyloid hypothesis of Alzheimer's disease

ISCTM 7th annual meeting to discuss drug development based on amyloid hypothesis of Alzheimer's disease

Focused Ultrasound Surgery Foundation releases men's heath update on prostate cancer, BPH treatments

Focused Ultrasound Surgery Foundation releases men's heath update on prostate cancer, BPH treatments

Omeros announces license agreement with Daiichi Sankyo for PDE7 inhibitors

Omeros announces license agreement with Daiichi Sankyo for PDE7 inhibitors

Cerasome filled molecular-sized bubbles to target liver cancer cells

Cerasome filled molecular-sized bubbles to target liver cancer cells

Positive results from Harbor BioSciences' Triolex initial preclinical study for treatment of PD

Positive results from Harbor BioSciences' Triolex initial preclinical study for treatment of PD

Infinity commences IPI-926 Phase 2 trial in patients with pancreatic cancer

Infinity commences IPI-926 Phase 2 trial in patients with pancreatic cancer

Gilead Sciences signs definitive agreement to acquire Calistoga for $375 million

Gilead Sciences signs definitive agreement to acquire Calistoga for $375 million

KemPharm commences KP201 Phase 1 trial for pain

KemPharm commences KP201 Phase 1 trial for pain

Pieris: New interim PRS-050 Phase I data against cancer to be presented at Tri-Conference in California

Pieris: New interim PRS-050 Phase I data against cancer to be presented at Tri-Conference in California

Protalix: New data from taliglucerase alfa, oral GCD trials to be presented at Lysosomal Disease Network Symposium

Protalix: New data from taliglucerase alfa, oral GCD trials to be presented at Lysosomal Disease Network Symposium

EMA grants Prima BioMed Scientific Advice for CVac ovarian cancer vaccine Phase III trial

EMA grants Prima BioMed Scientific Advice for CVac ovarian cancer vaccine Phase III trial

Researchers identify CD19-L protein that facilitates recognition, destruction of leukemia cells

Researchers identify CD19-L protein that facilitates recognition, destruction of leukemia cells

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.